现代医药卫生2024,Vol.40Issue(20) :3547-3552.DOI:10.3969/j.issn.1009-5519.2024.20.025

EZH2对肿瘤微环境中各种免疫细胞调控作用的研究进展

Research progress on the regulation of EZH2 on various immune cells in tumor microenvironment

邵芳斐 刘飞飞 杨倩倩
现代医药卫生2024,Vol.40Issue(20) :3547-3552.DOI:10.3969/j.issn.1009-5519.2024.20.025

EZH2对肿瘤微环境中各种免疫细胞调控作用的研究进展

Research progress on the regulation of EZH2 on various immune cells in tumor microenvironment

邵芳斐 1刘飞飞 2杨倩倩1
扫码查看

作者信息

  • 1. 浙江大学医学院附属邵逸夫医院血液内科二/细胞治疗中心,浙江 杭州 310020
  • 2. 浙江大学医学院附属邵逸夫医院血液内科一,浙江 杭州 310020
  • 折叠

摘要

表观遗传学修饰的动态调节在肿瘤的发生发展中起着重要作用.Zeste同源物增强子2(EZH2)在多种类型的肿瘤中异常表达或突变,参与组蛋白的表观遗传修饰,发挥致癌作用.目前,尚未完全明确EZH2的致癌作用和抑制EZH2所发挥的抗癌机制,免疫细胞与肿瘤细胞是通过肿瘤微环境交互作用的,EZH2对免疫细胞的调节也至关重要.该文在阐明EZH2在免疫细胞中的作用,特别是在癌症患者中,为EZH2的免疫治疗提供新思路.

Abstract

The dynamic regulation of epigenetic modifications plays an important role in the occurrence and development of tumors.Enhancer of zeste homolog 2(EZH2)is abnormally expressed or mutated in mul-tiple types of tumors,which is involved in epigenetic modification of histones and plays a carcinogenic role.At present,the carcinogenic effect of EZH2 and the anticancer mechanism of EZH2 inhibition have not been fully understood.Immune cells interact with tumor cells through tumor microenvironment,and EZH2 is also crucial for the regulation of immune cells.This review elucidate the role of EZH2 in immune cells,especially in cancer patients,and provides new ideas for the immunotherapy of EZH2.

关键词

EZH2/肿瘤免疫/肿瘤微环境/综述

Key words

EZH2/Tumor immunity/Tumor microenvironment/Review

引用本文复制引用

出版年

2024
现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
段落导航相关论文